Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag New antibiotic, gepotidacin, shows 92% effectiveness against drug-resistant gonorrhea in trials.

flag Researchers have developed a new antibiotic, gepotidacin, which shows promise in treating drug-resistant gonorrhea. flag In a Phase 3 trial, the pill was 92% effective, targeting key enzymes the bacteria need to survive. flag If approved, it would be the first new class of antibiotic for gonorrhea in over two decades. flag Though effective, challenges like limited funding and the rise of resistant strains highlight the need for continued research.

32 Articles